Search Results for "Glaucoma Moringa Clinical Study"

00:56 EDT 3rd May 2016 | BioPortfolio

Matching Channels

Matching News

Transcend Medical Submits Final Module of FDA Premarket Approval Application for the CyPass(R) Glaucoma Micro-Stent

MENLO PARK, CA--(Marketwired - October 22, 2015) - Transcend Medical, Inc., a pioneer of minimally invasive glaucoma surgery (MIGS), today announced the submission to the U.S. Food and Drug Administra...

FDA Approves InnFocus Glaucoma Study Expansion

MIAMI, Nov. 10, 2015 /PRNewswire/ -- InnFocus Inc. announces it has received approval from the U.S. Food and Drug Administration (FDA) to expand to the pivotal final phase of its randomized clinical s...

Envisia Therapeutics Announces First Patient Dosed in Second Cohort of Novel Phase 2 Program Evaluating ENV515 in Patients with Glaucoma

RESEARCH TRIANGLE PARK, N.C., Jan. 12, 2016 /PRNewswire/ -- Envisia Therapeutics, a clinical-stage biotechnology company focused on the development of novel extended-release therapies in ophthalm...

Transcend Medical and Glaukos Corporation Settle Patent Litigation

MENLO PARK, CA--(Marketwired - October 30, 2015) - Transcend Medical, Inc. (“Transcend”) announced today that it has reached agreement with Glaukos Corporation (“Glaukos”) to settle the patent...

InnFocus MicroShunt® 3-Year Results of a Long Term Clinical Trial Show Long Lasting IOP Reduction

MIAMI, Jan. 27, 2016 /PRNewswire/ -- Glaucoma patients treated in a prospective clinical trial with the InnFocus MicroShunt® Drainage System and followed for over three years experienced sig...

InnFocus Closes $33.9 Million Series C Financing

MIAMI, Dec. 22, 2015 /PRNewswire/ -- InnFocus, Inc. reports it has closed its Series C financing, which raised additional monies to total $33.9 million. The Company is developing the InnFocus MicroShu...

Global Glaucoma Surgical Devices Market 2016-2020

LONDON, Dec. 21, 2015 /PRNewswire/ -- Technavio's research analyst predicts the global glaucoma surgical devices market to grow rapidly at a CAGR of 41% during the forecast period. Much of this market...

Tropical plant called moringa shows promise in health, anti-aging products

Ilya Raskin is seeking cures and treatments for ailments afflicting hundreds of millions of people.

Matching PubMed Articles

Immunomodulatory activity of methanolic leaf extract of Moringa oleifera in Wistar albino rats.

Globally, Moringa oleifera is used by different communities to treat various ailments including modulation of the immune system though with limited scientific evidence.

Antidiabetic activities of aqueous ethanol and n-butanol fraction of Moringa stenopetala leaves in streptozotocin-induced diabetic rats.

Moringa stenopetala has been used in traditional health systems to treat diabetes mellitus. The aim of this study was to investigate the antidiabetic activity of aqueous ethanol and n-butanol fraction...

Occupational asthma to "the miracle tree" (Moringa oleifera): first description.

Moringa oleifera as an Anti-Cancer Agent against Breast and Colorectal Cancer Cell Lines.

In this study we investigated the anti-cancer effect of Moringa oleifera leaves, bark and seed extracts. When tested against MDA-MB-231 and HCT-8 cancer cell lines, the extracts of leaves and bark sho...

Some newer marker phytoconstituents in methanolic extract of Moringa oleifera leaves and evaluation of its immunomodulatory and splenocytes proliferation potential in rats.

The present study was undertaken to unravel the newer marker phytoconstituents in methanolic extract of Moringa oleifera leaves (MOLE) and evaluation of its immunomodulatory and splenocytes proliferat...

Search Whole site using Google

Quick Search
Advertisement Advertisement